The global lung cancer diagnostics market is anticipated to grow at a CAGR of 7.4% by 2023. Lung cancer occurs when cells of the lung become abnormal and begin to grow out of control. As more cancer cells develop, they form into a tumor and spread to other areas of the body. There are two types of lung cancer; Non-small cell lung cancer (NSCLC) and Small cell lung cancer (SCLC). Several factors such as pollution, smoking, passive smoking and other factors cause lunch cancer. There are several factors that are being considered for the cause of the lung cancer such as rising pollution due to the amount of carbon particles inhaled by humans. Robust healthcare expenditure within the developed countries, increasing pollution, Government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the growth of the market. Several signs and symptoms of lung cancer include coughing up blood, weight loss, chest pain, shortness of breath and others.

A full report description of Lung Cancer Diagnosis and Therapeutics Market at https://www.omrglobal.com/industry-reports/lung-cancer-diagnostics-market

The lung cancer diagnostics and therapeutics market has been segmented into by type, by treatment, by diagnosis, by stages, and by end user. On the basis type, the market has been bifurcated into non-small cell lung cancer and small cell lung cancer. According to therapy, the market has been bifurcated into chemotherapy, targeted therapy, immunotherapy, radiation therapy and others. Based on diagnostics, the market has been bifurcated into CT-scan, X-rays, lung cancer screening, needle biopsy, bronchoscopy, sputum cytology and others On the basis of end user, the market has been bifurcated into multispecialty hospitals and cancer research centers.

Request a Free Report on Sample of Lung Cancer Diagnosis and Therapeutics Market @ https://www.omrglobal.com/request-sample/lung-cancer-diagnostics-market

Lung Cancer Diagnosis and Therapeutics Market Segmentation

By Type

• Non-Small Cell Lung Cancer
• Small Cell Lung Cancer

By Therapy

• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Radiation Therapy
• Others

By Diagnosis

• Ct Scan
• X-Rays
• Lung Cancer Screening
• Needle Biopsy
• Bronchoscopy
• Sputum Cytology
• Others

By End User

• Multispeciality Hospitals
• Cancer Research Centers

Competitive Landscape

• Strategy Analysis
• Key Company Analysis

Regional Analysis

North America

• United States
• Canada

Europe

• United Kingdom
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• India
• China
• Japan

Rest of the World

Company Profiles

• Abbvie
• Arqule Inc.
• Astrazeneca Plc
• Bayer
• Boehringer .
• Bristol-Myers Squibb
• Celgene
• Daiichi Sankyo Co. Ltd.
• Eisai
• Eli Lilly And Company
• Genentech

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/lung-cancer-diagnostics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404